REQUEST A DEMO
Total
USD $0.00
Search more companies

Samjin Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Samjin Pharmaceutical Co.,Ltd. Profile Updated: July 04, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Samjin Pharmaceutical Co.,Ltd. is engaged in manufacturing of medicines and pharmaceutical products. The company offers Geworin, Neuracetam and Bamedin platless tablets. Samjin Pharmaceutical Co.,Ltd. is also developing new medicine such as AIDS preventive drug and oral therapeutic agent for dry eye syndrome. Samjin Pharmaceutical Co.,Ltd. is based in Seoul, South Korea. The company was incorporated in 1968.

Headquarters
338-8 Seogyo-Dong, Mapoh-Gu
Seoul; Seoul; Postal Code: 121-739

Contact Details: Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.samjinpharm.co.kr

Basic Information
Total Employees:
Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Samjin Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
April 18, 1968
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
President
Purchase this report to view the information.
President
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
12.09%
Purchase this report to view the information.
0.66%
Subsidiaries
한국제약협동조합
4.29%
제이티비씨
0.52%
얼머스Global Health Care 투자조합
Company Performance
Financial values in the chart are available after Samjin Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
6.64%
Total operating revenue
7.12%
Operating profit (EBIT)
-65.8%
EBITDA
-39.19%
Net Profit (Loss) for the Period
-62.59%
Total assets
29.93%
Total equity
13.59%
Operating Profit Margin (ROS)
-12.68%
Net Profit Margin
-9.93%
Return on Equity (ROE)
-8.82%
Debt to Equity Ratio
25.58%
Quick Ratio
-1.71%
Cash Ratio
-0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?